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ABSTRACT  
Schiff's bases are condensation products of primary amines with carbonyl compounds. Schiff bases (imines) possess wide variety of biological 
activities that include antibacterial and antifungal activity. In present work, Schiff bases from 3,5- Dimethoxyphenol (aryloxy moiety) as starting 
material synthesized. Esterification of 3,5- Dimethoxyphenol led to formation of (3,5-Dimethoxy-phenoxy)-acetic acid ethyl ester (1). (3,5-
Dimethoxy-phenoxy)-acetic acid hydrazide (2) is derived from Compound (1) by hydrazination. Compound (2) was reacted with different 
aromatic aldehydes to yield novel imines or Schiff bases (3A-I). The newly synthesized compounds were characterized on the basis of spectral 
studies and evaluated for antibacterial and antifungal activities. All the synthesized compounds had shown antibacterial and antifungal activity. 
Schiff bases 3C, 3D, 3E and 3I had shown good antimicrobial activity among all newly synthesized compounds. 
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INTRODUCTION 
The incidence of fungal and bacterial infections has increased 
dramatically in recent years [1]. Infection is a major category 
of human disease and skilled management of antimicrobial 
drugs is of the first importance. The accomplishment of 
antimicrobial agents, ranging from direct killing of invading 
pathogens to immune response modulation and other 
complex biological responses, has stimulated research and 
clinical interest for more than two decades. However the 
area is still flourishing due to emerging discoveries in the 
functions, roles and regulation of antimicrobial agents [2]. 
Schiff's bases are an important class of organic compounds 
[3]. They were first reported by Hugo Schiff in 1864 [4]. 
Structurally, a Schiff's base (also known as imine or 
azomethine) is a nitrogen analogue of an aldehyde or ketone 
in which the carbonyl group (>C = O) is replaced by an imine 
or azomethine group. Schiff's bases have also been shown to 
exhibit a broad range of biological activities, including 
antifungal, antibacterial, antimalarial, antiproliferative, anti-
inflammatory, antiviral, and antipyretic properties [5,6]. 
Imine or azomethine groups are present in various natural, 
naturally derived, and non-natural compounds. The imine 
group present in such compounds has been shown to be 
critical to their biological activities [7-10]. Kumar A et al. 
synthesized a series of Schiff bases of diphenylamine 
derivatives and evaluated in vitro for their antibacterial 
activity against pathogenic both Gram-positive bacteria B. 
subtilis and Gram-negative bacteria E. coli [11]. Azab ME et al. 
combined phthalazinones with 4-methoxybenzaldehyde to 
yield novel Schiff bases and tested against Bacillus subtilis 
and Staphylococcus aureus as Gram-positive bacteria, 
Escherichia coli and Pseudomonas aurignosa as Gram-
negative bacteria, and Candida albicans and Aspergillus niger 
as fungi strains [12]. Sharif HMA et al. reported synthesis and 
spectral data of eight Schiff bases of salicylaldehyde with 
different amines, and evaluation of their anti-microbial 
activities against different bacterial strains. All the bases 
showed moderate to good activities against all the tested 
microorganisms [13]. Schiff bases of p-bromo-m-cresol were 
reported by Fuloria NK et al. The newly synthesized 
compounds were characterized on the basis of spectral 
studies and evaluated for antibacterial and antifungal 
activities [14]. It is clear from the literature review & market 
demand, that Schiff bases (imines) possesses wide variety of 
biological activities like antimicrobial, antitubercular, 
antimalarial and antiviral. Among various biological 
activities of several Schiff bases molecules synthesized in 
literature, the antimicrobial activity was found to be very 
prominent. According to literature it was also known that 
Esters, Hydrazides and Imines can be synthesized from 
different moieties. So, in the view of medicinal importance 
and synthetic routes to Schiff bases, it was thought 
worthwhile to study and synthesize compounds possessing 
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imino group. It was pertinent to investigate their structural 
modification. Hence the aim of present study was to 
synthesize and evaluate antimicrobial activity of Schiff bases 
of aryloxy Moiety. 
EXPERIMENTAL 
Melting points of newly synthesized compounds were 
determined in open capillary tubes. IR spectra were recorded 
(in KBr) on Schimadzu FTIR Spectrophotometer, 1H NMR 
spectra on BRUKER Avance-II 400 MHz instrument using 
CDCl3 solvent and mass spectra on LCMS 2010 EV 
SHIMADZU Mass spectrometer.  
2.1 Ethyl aryloxy acetate (1): A mixture of aryloxy 
compound (0.1mol), ethylchloro acetate (0.1 mol) and 
anhydrous potassium carbonate (0.15 mol) in dried acetone 
was refluxed for 24 h. Resultant mixture was distilled off and 
poured on to ice-cold water and stirred. Residue was 
extracted with ether and the extract was dried over 
anhydrous sodium sulphate and was purified under reduced 
pressure to yield compound 1; yield (62.74%), b.p. (3050c), 
IR 1745 C=O of ester, 1149 for C-O of ester.  
2.2 Acetohydrazide (2): A mixture of compound 1 
(0.05mol) and hydrazine hydrate (0.075 mol) in ethanol was 
refluxed for 8 h and after distilling off the solvent the residue 
was recrystallized from methanol to yield compound 2; yield 
(70.00%), m.p. (1340c), IR 3306, 3198 for N-H and NH2, 1674 
for C=O of amide, 1524 for N-H bending of amide, 1250 and 
1065 for C-O of phenyl ether. 
2.3 Schiff bases (3A-I): A mixture of compound 2 (0.001 
mol) and aromatic aldehyde (0.001 mol) was refluxed for 8 h 
using ethanol and glacial acetic acid. Crystals formed were 
washed with ice-cold water, dried and recrystallized from 
methanol to yield compounds 3A-I [15,16]. 
2.4 Screening for biological activity: The synthesized 
compounds 3A-I were screened for antibacterial activity 
using Staphylococcus aureus (MTCC 737), Escherichia coli 
(MTCC 452) and antifungal activity using Candida albicans 
(MTCC 227) by disk diffusion method at a concentration of 2 
mg/mL using DMF as solvent. Ampicillin 1 mg/mL and 
fluconazole 2.5 mg/mL were used as standards [17]. The 
results were recorded using ampicillin and fluconazole as 
standards are given in Table-4. 
RESULTS AND DISCUSSION 
The synthetic route is outlined in Scheme-I. (3,5-Dimethoxy-
phenoxy)-acetic acid ethyl ester (1) was synthesized by 
refluxing 3,5-Dimethoxyphenol with ethylchloroacetate in 
dry acetone. Compound 1 on reacting with hydrazine 
hydrate gave (3,5-Dimethoxy-phenoxy)-acetic acid hydrazide 
(2). Condensation of 2 with various aromatic aldehydes 
afforded the potent antibacterial and antifungal Schiff bases 
(3A-I). Physical data of 3A-I are given in Table-1. The 
structures of all compounds were characterized by spectral 
analysis. All the synthesized compounds 3A-I had shown 
antibacterial and antifungal activity to certain extent. From 
the compounds synthesized, compounds 3C, 3D, 3E and 3I 
had shown good antibacterial and antifungal activity and the 
remaining compounds have shown moderate activity on 
tested organisms (Table-4). 
 
 
Scheme – I: Conversion of aryloxy moiety into Schiff bases 
First of all nucleophilic substitution reaction take place between 3,5-Dimethoxyphenol and ethylchloroacetate in the basic 
medium to produce the corresponding ethyl ester (1). 
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The second step involves the synthesis of acid hydrazide through the reaction between hydrazine and the ethyl ester (1). The 
reaction proceeds by nucleophilic substitution of hydrazine to the ethyl ester carbonyl group to give the corresponding 
hydrazide (2). 
 
The final step involves nucleophilic attack by the basic nitrogen compound on carbonyl carbon. Protonation of carbonyl oxygen 
in presence of acid makes carbonyl carbon more susceptible to nucleophilic attack. The addition product undergoes 
dehydration to produce Schiff bases (3A-I). 
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Table – 1: Physical characteristics of synthesized compounds 3A-I 
Compound 
(M.F.) 
Ar’ (aryl group) 
Molecular 
Weight 
Yield (%)  M.P. (0c) 
3A 
(C20H20 N4O4) 
 
380.41 
 
72.00 
 
134 
3B 
(C18H17F3N2O5) 
 
398.34 
 
78.22 
 
144 
3C 
(C15H15N3O6S) 
 
365.37 
 
69.48 
 
150 
3D 
(C21H25N3O4) 
 
383.45 
 
80.00 
 
140 
3E 
(C15H18N4O4) 
 
318.34 
 
80.60 
 
130 
3F 
(C17H18N2O4) 
 
314.34 
 
48.42 
 
140 
3G 
(C17H19N3O4) 
 
329.36 
 
70.82 
 
156 
3H 
(C18H17F3N2O4) 
 
382.34 
 
86.24 
 
124 
3I 
(C20H21N3O4) 
 
367.41 
 
      82.00 
 
160 
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Table 2: Mass and 1H-NMR data of 3A-3I 
Compd. Mass (M/Z) 1H-NMR (ppm) 
3A 380.2[M+], 381.2 
[M+1] 
3.71-3.73 (6H, s, for OCH3), 5.13 (2H, s, for O-CH2-CO), 6.10-6.19 (3H, m, for Ar-H), 
7.47 (1H, dd, for imidazole-H), 7.82-7.84 (2H, ddd, for Ar-H), 7.88-7.90 (1H, dd, for 
imidazole-H), 8.04-8.07 (2H, ddd, for Ar-H), 8.41 (1H, s, for N=CH), 8.93-8.95 (1H, dd, 
for imidazole-H), 11.71 (1H, s, for NH). 
3B 398.2[M+], 399.2 
[M+1] 
3.70-3.72 (6H, s, for OCH3), 5.10 (2H, s, for O-CH2-CO), 6.08-6.18 (3H, m, for Ar-H), 
7.42-7.50 (2H, m, for Ar-H), 8.06-8.08 (2H, m, for Ar-H), 8.38 (1H, s, for N=CH), 11.67 
(1H, s, for NH) 
3C 365.3[M+], 366.3 
[M+1] 
3.74 (6H, s, for OCH3), 5.10 (2H, s, for O-CH2-CO), 6.26-6.28 (3H, m, for Ar-H), 7.55-
7.58 (2H, d, for thiophene-H), 8.07 (1H, s, for N=CH), 11.08 (1H, s, for NH) 
3D 383.2[M+], 384.2 
[M+1] 
1.88 (4H, m, for pyrazolidine-H), 3.46-3.48 (4H, m, for pyrazolidine-H), 3.70-3.72 
(6H, s, for OCH3), 5.10 (2H, s, for O-CH2-CO), 6.20-6.30 (3H, m, for Ar-H), 6.71 (2H, 
ddd, for Ar-H), 7.38 (2H, ddd, for Ar-H), 8.05 (1H, s, for N=CH), 11.54  (1H, s, for NH) 
3E 318.3[M+], 319.3 
[M+1] 
3.59 (3H, s, for N-CH3), 3.74-3.76 (6H, s, for OCH3),  5.10 (2H, s, for O-CH2-CO), 6.20-
6.23 (3H, m, for Ar-H), 7.30 (1H, d, for imidazole-H), 7.40 (1H, d, for imidazole-H), 
7.78 (1H, s, for N=CH), 10.58 (1H, s, for NH) 
3F 314.2[M+], 
315.2[M+1] 
3.74-3.76 (6H, s, for OCH3), 5.13 (2H, s, for O-CH2-CO), 6.26-6.32 (3H, m, for Ar-H), 
7.20-7.42 (5H, m, for Ar-H), 8.12 (1H, s, for N=CH), 10.88 (1H, s, for NH) 
3G 329.2[M+], 
330.2[M+1] 
2.52-2.54 (3H, s, for pyridine-CH3), 3.70-3.72 (6H, s, for OCH3), 5.12 (2H, s, for O-CH2-
CO), 6.19-6.24 (3H, m, for Ar-H), 7.19-7.52 (3H, m, for pyridine-H), 7.98 (1H, s, for 
N=CH), 10.10 (1H, s, for NH) 
3H 382.2[M+], 383.2 
[M+1] 
3.74 (6H, s, for OCH3), 5.08 (2H, s, for O-CH2-CO), 6.20-6.22 (3H, m, for Ar-H), 7.41-
7.66 (4H, m, for Ar-H), 8.02 (1H, s, for N=CH), 10.58 (1H, s, for NH) 
3I 367.3[M+], 368.3 
[M+1] 
3.67-3.69 (3H, s, for N-CH3), 3.72-3.74 (6H, s, for OCH3), 5.13 (2H, s, for O-CH2-CO), 
6.20-6.23 (3H, m, for Ar-H), 7.21 (1H, t, for pyrrole-H), 7.38-7.54 (4H, m, for Ar-H), 
8.10 (1H, s, for N=CH), 11.28  (1H, s, for NH) 
 
Table 3: IR spectral data of compounds 3A-I 
Compd IR (cm-1) 
3A 3113 for N-H, 2970 for aliphatic C-H, 1697 for C=O of amide, 1609 for C=N of imines, 1524 for N-H bending 
of amide, 1261 and 1061 for C-O of phenyl ether 
3B 3198 for N-H, 3082 for aromatic C-H, 2970 for aliphatic C-H, 1693 for C=O of amide, 1605 for C=N of imines, 
1508 for N-H bending of amide, 1261 and 1072 for C-O of phenyl ether 
3C 3113 for N-H, 3048 for aromatic C-H, 2963 for aliphatic C-H, 1686 for C=O of amide, 1612 for C=N of imines, 
1528 for N-H bending of amide, 1281 and 1042 for C-O of phenyl ether 
3D 3202 for N-H, 3044 for aromatic C-H, 2967 for aliphatic C-H, 1674 for C=O of amide, 1609 for C=N of imines, 
1524 for N-H bending of amide, 1246 and 1053 for C-O of phenyl ether 
3E 3132 for N-H, 3102 for aromatic C-H, 2994 for aliphatic C-H, 1701 for C=O of amide, 1609 for C=N of imines, 
1524 for N-H bending of amide, 1285 and 1069 for C-O of phenyl ether 
3F 3190 for N-H, 3028 for aromatic C-H, 2916 for aliphatic C-H, 1686 for C=O of amide, 1597 for C=N of imines, 
1555 for N-H bending of amide, 1292 and 1030 for C-O of phenyl ether 
3G 3059 for N-H, 2997 for aromatic C-H, 2947 for aliphatic C-H, 1717 for C=O of amide, 1624 for C=N of imines, 
1539 for N-H bending of amide, 1250 and 1080 for C-O of phenyl ether 
3H 3202 for N-H, 2986 for aromatic C-H, 2963 for aliphatic C-H, 1701 for C=O of amide, 1605 for C=N of imines, 
1516 for N-H bending of amide, 1242 and 1069 for C-O of phenyl ether 
3I 3102 for N-H, 3044 for aromatic C-H, 2943 for aliphatic C-H, 1690 for C=O of amide, 1620 for C=N of imines, 
1524 for N-H bending of amide, 1254 and 1076 for C-O of phenyl ether 
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Table 4: Antimicrobial activity of compounds 3A-I 
Compound number Zone of inhibition in mm 
Antibacterial activity Antifungal activity 
S. aureus E. coli C. albicans 
3A 15 16 10 
3B 18 19 12 
3C 25 26 17 
3D 21 22 14 
3E 24 24 15 
3F 20 18 13 
3G 18 18 12 
3H 16 16 10 
3I 22 22 15 
Ampicillin 25 24 --- 
Fluconazole --- --- 17 
 
CONCLUSION:  
Antibiotic resistance is a serious and growing phenomenon 
in contemporary medicine and has emerged as one of the 
eminent public health concerns of the 21st century, 
particularly as it pertains to pathogenic organisms. Hence in 
recent years, there has been a growing interest in 
researching and developing new antimicrobial agents from 
various sources to combat microbial resistance. Schiff bases 
(imines) possess wide variety of biological activities like 
antimicrobial, antitubercular, antimalarial and antiviral. 
Among various biological activities of several Schiff bases 
molecules synthesized in literature, the antimicrobial activity 
was found to be very prominent. It was also observed that 
Esters, Hydrazides and Imines can be synthesized from 
different moieties. From FTIR spectroscopy, it was concluded 
that the compounds were synthesized successfully as spectra 
includes different stretching bands for characteristics 
functional groups. The structures of Schiff bases were further 
confirmed by their 1H-NMR and mass spectroscopy. After 
carrying out the antimicrobial studies of newly synthesized 
compounds it was found that each compound 3A to 3I 
possesses antibacterial and antifungal activities to certain 
extent. Among newly synthesized derivatives, compound 3C 
was found to be more potent than ampicillin when tested 
against the strains of Escherichia coli, whereas compounds 
3E was found to be equipotent to ampicillin and fluconazole 
when tested on Staphylococcus aureus, Escherichia coli and 
Candida albicans. Schiff bases containing nitro thiophene 
nucleus has exhibited highest antimicrobial activity among 
all newly synthesized compounds. 
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